You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新股消息 | "生殖基因檢測龍頭"貝康醫療週一開始摸底香港IPO需求
uSMART盈立智投 01-18 08:09

根據彭博新聞社獲得的交易文件,蘇州貝康醫療股份有限公司週一開始評估其擬在香港進行的首次公開募股(IPO)的投資者需求,即上市前路演的意思。

此前的披露易網站顯示,貝康醫療已於1月17日更新聆訊後版本招股書,這意味着貝康醫療已通過聆訊。

根據初步招股說明書,中信裏昂證券是唯一保薦人。

據招股書顯示,貝康醫療是中國輔助生殖基因檢測解決方案最領先創新平臺,也是中國唯一一家擁有覆蓋整個生殖週期的基因檢測試劑盒產品線的公司。

所得款項將用於其核心產品胚胎植入前非整倍體篩查(PGT-A)試劑盒;胚胎植入前單基因遺傳學檢測(PGT-M)試劑盒的臨牀試驗、註冊備案和商業化;其他產品的開發、臨牀試驗和註冊;提高研發能力和技術水平;以及 一般企業目的。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account